Joseph Todisco
CEO
CEO
Chairman
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CorMedix Inc. (CRMD) | Chief Executive Officer | $684,353 | $6,101,176 |
| 2024 | CorMedix Inc. (CRMD) | Chief Executive Officer | $639,214 | $2,359,908 |
| 2023 | CorMedix Inc. (CRMD) | Chief Executive Officer | $616,962 | $2,459,342 |
| 2022 | CorMedix Inc. (CRMD) | Chief Executive Officer | $378,461 | $2,691,189 |
| 2021 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Specialty | $523,615 | $2,156,610 |
| 2020 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Commercial Officer - Specialty | $458,539 | $1,671,129 |
Executive changes
- 2026-01-08
- 2024-11-21
- 2022-03-18
- 2022-03-21
-
Resigned Executive Vice President, Chief Commercial Officer – Specialty at Amneal Pharmaceuticals, Inc. (AMRX)2022-03-15
Earnings-call appearances
-
CorMedix Inc. Q1 FY2026 Earnings Call2026-05-14
CorMedix Inc. (CRMD)
-
CorMedix Inc. Q3 FY2025 Earnings Call2025-10-20
CorMedix Inc. (CRMD)
-
CorMedix Inc. Q2 FY2025 Earnings Call2025-08-07
CorMedix Inc. (CRMD)
-
CorMedix Inc. Q1 FY2024 Earnings Call2024-05-09
CorMedix Inc. (CRMD)
-
CorMedix Inc. Q3 FY2023 Earnings Call2023-11-14
CorMedix Inc. (CRMD)
-
CorMedix Inc. Q2 FY2023 Earnings Call2023-08-08
CorMedix Inc. (CRMD)
-
CorMedix Inc. Q2 FY2022 Earnings Call2022-08-11
CorMedix Inc. (CRMD)
-
Amneal Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-05-07
Amneal Pharmaceuticals, Inc. (AMRX)
-
Amneal Pharmaceuticals, Inc. Q3 FY2020 Earnings Call2020-11-06
Amneal Pharmaceuticals, Inc. (AMRX)
-
Amneal Pharmaceuticals, Inc. Q2 FY2020 Earnings Call2020-08-06
Amneal Pharmaceuticals, Inc. (AMRX)